Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026
SAN FRANCISCO , April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Continuous Renal Replacement Therapy (CRRT) - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
What's New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
Edition: 9; Released: February 2022
Executive Pool: 5928
Companies: 18 - Players covered include Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International, Inc.; Bellco Societa Unipersonale a r.l; Chongqing Shanwaishan Science and Technology Co., Ltd.; Fresenius Medical Care AG & Co. KgaA; Infomed SA; Medica SpA; Medical Components, Inc.; Medites Pharma Spol. S.R.O.; Medtronic PLC; Nikkiso Co., Ltd.; Ningbo Tianyi Medical Appliance Co., Ltd; NxStage Medical, Inc.; Toray Medical Co., Ltd. and Others.
Coverage: All major geographies and key segments
Segments: Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration, Slow Continuous Filtration); Product (Dialysates & Replacement Fluids, and Disposables & Systems)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
ABSTRACT-
Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026
Continuous renal replacement therapy (CRRT) is the most widely used therapy in critically ill patients as these hypotensive patients require slow removal of waste and water without causing hypotension. As renal replacement therapy for pediatric patients with Acute Kidney Injury (AKI) becomes more commonplace, CRRT gains traction as a suitable treatment modality for patients of any size and who are hemodynamically unstable. The growing prevalence of cardiovascular diseases is the underlying factor for acute kidney injury cases, which is expected to drive the demand for CRRT. Amid the COVID-19 crisis, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.7 Billion by 2026, registering a compounded annual growth rate (CAGR) of 5.8% over the analysis period. The United States represents the largest regional market for Continuous Renal Replacement Therapy (CRRT), and is projected to reach US$422.4 Million by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 8.3% over the analysis period.
The global Continuous Renal Replacement Therapy (CRRT) market is expected to increase rapidly in future, driven by rising incidence of acute kidney injury (AKI). AKI constitutes for about 60% mortality rate. CRRT is the most widely used treatment for AKI. The technique is the most preferred modality for treating and managing hemodynamically unstable patients with AKI. Benefits of CRRT include hemodynamic tolerance due to solute removal and slower ultrafiltration. Rise in ageing population, increase in ICU-related admissions, and higher acceptance of CRRT procedures due to clinical advantages over the intermittent blood purification methods are the other key factors driving market growth. As Renal replacement therapy (RRT) is required in patients with severe acute kidney injury (AKI), the rise in incidence of Acute Kidney Injury remains a major factor driving growth in the CRRT market. Renal disorders and kidney related ailments are also common among aged people, and spike in population of aged people inflates the potential patient population for CRRT treatments.
Europe and the United States dominate the Continuous Renal Replacement Therapy market, driven by the fast growing aging population and increasing acute kidney injury cases. Growth in Asia-Pacific region is attributable to increasing aging population, rising cases of acute kidney injury/diseases, increasing healthcare expenditure, technological advancements, and governments' push for investments in the healthcare sector. The market for Continuous Venovenous Hemodiafiltration (CVVHDF) is forecast to grow at the fastest rate among all modalities over the analysis period. CVVHDF treatment modality leads to comprehensive removal and replacement of fluids and blood in the blood. The modality combines the principles of convection and diffusion, hemodialysis and hemofiltration, by using an efficient hemodiafilter. Given the modality's ability to eliminate solute as well as fluid, the CVVHDF segment is poised to grow at a strong pace in the coming years. CVVHDF is a modality that is generally preferred among hospitals equipped with well-established intensive care units. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]
LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter
https://twitter.com/marketbytes
Journalists & Media
[email protected]
SOURCE Global Industry Analysts, Inc.
Share this article